# Brimonidine

## Mirvaso 3mg/gm gel, 30gm

| TAH Drug Code      | [**EMIR3**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=EMIR3)                                                                                                                                                                                                 |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Symptomatic treatment of facial erythema of rosacea in adult patients.                                                                                                                                                                                                     |
| Dosing             | Rosacea, Persistent (nontransient) facial erythema Apply once daily as long as facial erythema is present. Max daily recommended dose: 1 g gel, divided into 5 pea size amounts on forehead, cheeks, nose & 2- chin smooth evenly over entire face avoiding lips and eyes. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                              |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                              |
| Contraindications  | Hypersensitivity. Patients receiving MAOIs (eg, selegeline or moclobemide) & tricyclic (eg, imipramine) or tetracyclic (eg, maprotiline, mianserin or mirtazapin) antidepressants. Do not use in childn or adolescents 2-18 yr or childn <2 yr.                            |
| Adverse Effects    | Flushing, erythema, pruritus, skin burning sensation.                                                                                                                                                                                                                      |
| Pregnancy          | No (Limited) Human Data â€“ Probably Compatible                                                                                                                                                                                                                              |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                              |

